About
BioGeometry applies generative AI to protein design for biomedicine and synthetic biology. It operates AI and wet-lab platforms in Beijing and Shanghai, with a wet lab in Beijing and an R&D center in Shanghai.
Services
Protein design and optimization
Uses an AI-driven biologics design platform and high-throughput wet-lab validation in a design-build-test-learn loop for precise protein design and optimization.
Antibody design
Generates and optimizes antibodies, including epitope-specific de novo antibody design and antibody binder evolution.
Enzyme optimization
Optimizes enzymes for catalytic activity, stereoselectivity, pH stability, and thermostability.
Enzyme mining
Discovers enzymes for biochemical reactions and develops biocatalytic routes from scratch.
Synthetic biology solutions
Provides project-based synthetic biology solutions for applications in bio-manufacturing and sustainable products.
Bio-manufacturing support
Supports bio-manufacturing of products with enhanced yield and minimized pollution.
CDMO: development & manufacturing
AI-driven protein design
Uses generative AI to design and optimize proteins for biomedicine and synthetic biology.
Biologics design platform
Provides an AI-driven biologics design platform called GeoBiologics for protein design and optimization.
High-throughput wet-lab validation
Runs wet-lab experiments to validate AI-designed molecules in a design-build-test-learn loop.
De novo protein design
Designs novel proteins using generative diffusion models and geometric deep learning.
Antibody generation and optimization
Generates and optimizes epitope-specific antibodies and other biologics.
Enzyme engineering
Applies generative AI to improve enzymatic activity, sequence novelty, pH stability, thermo-stability, and stereo-selectivity.
Protein structure prediction
Develops self-developed protein and antibody structure prediction methods integrated into its pipelines.
Antibody affinity maturation
Uses geometric deep learning and pretraining to improve antibody affinity.
Protein-ligand docking
Provides end-to-end equivariant protein-ligand docking methods.
Protein sequence and structure co-design
Co-designs protein sequence and structure with equivariant translation methods.
- Turnaround
- 55 days · Two months · 3 weeks
Capabilities
- Assays and studies
- Antibodies · High-throughput wet-lab validation · Structure prediction · Affinity maturation · In silico evolution · De novo design · Wet-lab validation · Protein structure prediction · Protein-ligand docking · Sequence-structure co-design
- Therapeutic areas
- Biomedicine · Synthetic biology
Modalities and species
- Modalities
- Antibody
Industries served
- Biomedicine
- Synthetic biology
- Biomanufacturing
- Drug discovery
- IVD
Company
- Type
- CRO
- Founded
- 2022
Locations
- Address
- 158 Gu'en Road, Shanghai, China, 201314 Business Collaboration bd
- Sites
- Beijing, China · Shanghai, China
Similar labs
Work here? Claim this listing